Edgewise Therapeutics Inc. Common Stock vs The Magnum Ice Cream Company N.V. Ordinary Shares — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.13 (market cap $3.94B), while The Magnum Ice Cream Company N.V. Ordinary Shares trades at $18.49 (market cap $10.72B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares is far larger — about 2.7× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is more actively traded (810,104 versus 1,309,650). Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days on average.
| EWTX | MICC | |
|---|---|---|
Market Cap | $3.94B | $10.72B |
Volume | 810,104 | 1,309,650 |
Sector | Health | Consumer Staples |
52-Week High | $48.35 | $20.42 |
52-Week Low | $14.89 | $13.06 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $14.14B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →